Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Upton

Showing results (231-240 of 254) with videos related to

Pageof 26
Sort By:
American Journal of Respiratory and Critical Care Medicine|March 8, 2022
Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical TrialVeronique De Jager, Nikhil Gupte, Silvia Nunes, et al.
Clinical and Translational Allergy|December 12, 2025
Safety and Efficacy of Very Low-Dose Multi-Nut Oral Immunotherapy in ChildrenJulia E M Upton, Carmen H Li, Alireza Berenjy, et al.
Allergy|May 25, 2019
Extract and component-specific sensitization patterns in Canadian moderate-to-severe preschool asthmaticsJennifer A Hoang, Pouria Mashouri, Ruixue Dai, et al.
Nature Medicine|February 16, 2024
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trialAndreas H Diacon, Clifton E Barry, Alex Carlton, et al.
International Archives of Allergy and Immunology|September 9, 2025
Clinical Presentation, Triggers, Comorbidities, and Management of Anaphylaxis in the Elderly: A Cross-Sectional StudyRoy Khalaf, Rawan Saleem, Connor Prosty, et al.
ACS Infectious Diseases|January 6, 2023
Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome <i>bd</i> and Chemical Validation of Combination Strategies for Respiratory Inhibitors against <i>Mycobacterium tuberculosis</i>Laura N Jeffreys, Alison Ardrey, Taghreed A Hafiz, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 8, 2024
Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinomaDaniel S K Liu, Jisce R Puik, Bhavik Y Patel, et al.
The Journal of Allergy and Clinical Immunology|September 24, 2022
Epigenetic and immunological indicators of IPEX disease in subjects with FOXP3 gene mutationMansi Narula, Uma Lakshmanan, Simon Borna, et al.
Contemporary Clinical Trials|September 7, 2025
Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB designEkaterina V Kurbatova, Kelly E Dooley, Wendy Carr, et al.
Vaccine|June 23, 2024
Revaccination outcomes among adolescents and adults with suspected hypersensitivity reactions following COVID-19 vaccination: A Canadian immunization research network studyTiffany Fitzpatrick, Peter Yamoah, Gina Lacuesta, et al.
Pageof 26

Showing results (231-240 of 254) with videos related to

Sort By:
Pageof 26
American Journal of Respiratory and Critical Care Medicine|March 8, 2022
Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical TrialVeronique De Jager, Nikhil Gupte, Silvia Nunes, et al.
Clinical and Translational Allergy|December 12, 2025
Safety and Efficacy of Very Low-Dose Multi-Nut Oral Immunotherapy in ChildrenJulia E M Upton, Carmen H Li, Alireza Berenjy, et al.
Allergy|May 25, 2019
Extract and component-specific sensitization patterns in Canadian moderate-to-severe preschool asthmaticsJennifer A Hoang, Pouria Mashouri, Ruixue Dai, et al.
Nature Medicine|February 16, 2024
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trialAndreas H Diacon, Clifton E Barry, Alex Carlton, et al.
International Archives of Allergy and Immunology|September 9, 2025
Clinical Presentation, Triggers, Comorbidities, and Management of Anaphylaxis in the Elderly: A Cross-Sectional StudyRoy Khalaf, Rawan Saleem, Connor Prosty, et al.
ACS Infectious Diseases|January 6, 2023
Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome <i>bd</i> and Chemical Validation of Combination Strategies for Respiratory Inhibitors against <i>Mycobacterium tuberculosis</i>Laura N Jeffreys, Alison Ardrey, Taghreed A Hafiz, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 8, 2024
Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinomaDaniel S K Liu, Jisce R Puik, Bhavik Y Patel, et al.
The Journal of Allergy and Clinical Immunology|September 24, 2022
Epigenetic and immunological indicators of IPEX disease in subjects with FOXP3 gene mutationMansi Narula, Uma Lakshmanan, Simon Borna, et al.
Contemporary Clinical Trials|September 7, 2025
Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB designEkaterina V Kurbatova, Kelly E Dooley, Wendy Carr, et al.
Vaccine|June 23, 2024
Revaccination outcomes among adolescents and adults with suspected hypersensitivity reactions following COVID-19 vaccination: A Canadian immunization research network studyTiffany Fitzpatrick, Peter Yamoah, Gina Lacuesta, et al.
Pageof 26